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 KnEE
The importance of plasmin for the 
healing of the anterior cruciate ligament
Aims
The anterior cruciate ligament (ACL) is known to have a poor wound healing capacity, where-
as other ligaments outside of the knee joint capsule such as the medial collateral ligament 
(MCL) apparently heal more easily. Plasmin has been identified as a major component in the 
synovial fluid that varies among patients. The aim of this study was to test whether plasmin, 
a component of synovial fluid, could be a main factor responsible for the poor wound heal-
ing capacity of the ACL.
Methods
The effects of increasing concentrations of plasmin (0, 0.1, 1, 10, and 50 µg/ml) onto the 
wound closing speed (WCS) of primary ACL- derived ligamentocytes (ACL- LCs) were tested 
using wound scratch assay and time- lapse phase- contrast microscopy. Additionally, relative 
expression changes (quantitative PCR (qPCR)) of major LC- relevant genes and catabolic 
genes were investigated. The positive controls were 10% fetal calf serum (FCS) and platelet- 
derived growth factor (PDGF).
Results
WCS did not differ significantly among no plasmin versus each of the tested concentrations 
(six donors). The positive controls with PDGF and with FCS differed significantly from the 
negative controls. However, we found a trend demonstrating that higher plasmin concen-
trations up- regulate the expression of matrix metalloproteinase 13 (MMP13), 3 (MMP3), and 
tenomodulin (TNMD).
Conclusion
The clinical relevance of this study is the possibility that it is not solely the plasmin, but also 
additional factors in the synovial fluid of the knee, that may be responsible for the poor heal-
ing capacity of the ACL.
Cite this article: Bone Joint Res 2020;9(9):543–553.
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Article focus
 This hypothesis was tested using primary 
ACL- derived ligamentocytes (ACL- LCs) 
in wound scratch assays using real- time 
microscopy and quantitative PCR (qPCR) 
at genes relevant for the ligament.
Key messages
 Platelet- derived growth factor (PDGF) 
and fetal calf serum (FCS) controls mark-
edly boosted the wound closure speed 
(WCS).
 It could be demonstrated that increasing 
plasmin concentration had a notable 
effect on the wound closing rate (WCR) 
of ACL- LCs in vitro in four out of the six 
analyzed donors, in particular increasing 
the plasmin concentration to 50 µg/ml, 
which is equivalent value of plasmin 
concentration in the synovial fluids.
 Relative gene expression revealed 
that MMP13 expression seemed to 
be dependent on increasing plasmin 
concentrations.
Strengths and limitations
 The article tests for the first time the 
importance of plasmin in the synovial 
fluid as a possible player for inhibition of 
wound healing in the ACL.
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 The article reports on a newly established image 
processing chain using real- time microscopy phase- 
contrast images, which are able to accurately segment 
wound scratch assays using primary ACL- LCs.
 Although up to 50 µg/ml of plasmin was tested no 
inhibiting effect could be demonstrated across all 
six human donors. Possibly other unknown factors 
in the synovial fluid may be responsible for the 
observed low wound healing potential of the ACL.
Introduction
Rupture of the ACL is a widespread knee injury. The 
annual incidence in the USA is estimated to lie between 
100,000 to 200,000 cases.1,2 ACL tears mostly occur as a 
result of rotational forces alongside varus/valgus stresses 
acting on the knee. Furthermore, about 80% of all ACL 
incidences are so- called 'non- contact' injuries that 
happen due to unfortunate knee positioning and a strong 
unopposed quadriceps contraction.3,4 It is generally well- 
accepted that ACL ruptures have a very poor self- healing 
capacity. As for the regeneration of this tissue, tendon- 
specific stem cells might become an option in the future. 
However, more evidence on the safe application of these 
cell populations and their fate would be required for clin-
ical translation.5,6
In 2014 Kiapour and Murray3 raised an interesting 
theory to explain the relatively poor wound healing 
potential of the ACL compared with other ligaments such 
as the medial collateral ligament (MCL)3 (see Figure 1). 
They questioned whether the poor healing capacity 
of the ACL was due to the presence or absence of scar 
formation, which might be directly linked to the pres-
ence or absence of fibrin blood clot formation during the 
healing process.3,7 It would be important to know the 
composition of the synovial fluid in such a case. The main 
constituents of the synovial fluid are hyaluronic acid, 
collagen, and fibronectin. A deficiency in the lubrication 
system may contribute to erosion of cartilage surfaces 
and can lead to arthritis. Several studies have reported 
on the composition of synovial fluid and demonstrated 
increased concentrations of plasmin.8,9 It has been shown 
in synovial fluid of patients with knee trauma, versus 
healthy control patients, that there is an increase of 
proteolytic enzymes such as elastase, collagenase, and 
cathepsin G, which could also potentially threaten struc-
tural elements of the enclosed cartilage.10 Furthermore, 
it was argued that this might be due to the presence of 
plasmin and/or plasmin activator in the synovial fluid 
(see Figure  1).11 Indeed, it could be the synovial fluid, 
also known as diarthrosis, that might be responsible for 
the delayed wound healing response.12 Biochemically it is 
an ultrafiltrate of plasma across the synovial membrane 
enriched with various compounds produced by 'synov-
iocytes' (the total of cells in and around the synovium). 
Here, the effects of different plasmin concentrations on 
the wound closing rate (WCR) of primary ligamentocytes 
(LCs) isolated from primary patient- derived human ACLs 
(referred as ACL- LCs) were tested experimentally in a 
simplified 'wound' using scratch wound assays. In injured 
knees, the plasmin concentrations were determined to 
lie between 5 µg/ml and 50 µg/ml.13,14 Therefore, this 
concentration range should be considered when testing 
the influence of plasmin on ACL- LCs.
In this study, it was the aim to determine the effect of 
different plasmin concentrations on the specific response 
of primary human- derived ACL- LCs using standardized 
wound scratch assays. Furthermore, we investigated 
for the first time the changes in gene expression using 
selected ACL- LC specific genes, i.e. collagenase 1A2 (col 1) 
and collagenase 3A1 (col3A1), tenascin C (TNC), tenomod-
ulin (TNMD), and catabolic genes such as MMP3, MMP13, 
and ADAMTS4 with respect to increasing doses of plasmin.
Methods
Primary ACL-LCs isolation and culture conditions. The ACL 
tissue was obtained from surgeries of the knee team at 
the Insel Hospital, University of Bern, Switzerland, with 
ethical approval and written consent of the patients. The 
tissue sample was placed in a tissue culture dish contain-
ing phosphate buffered saline (PBS) and cut into small 
pieces of approximately 0.3 cm3. Cells were then har-
vested by mild overnight digestion with 275 U/mg col-
lagenase type II (Worthington Biochemical Corporation, 
Lakewood, New Jersey, USA) that was added to 25 ml low 
glucose Dulbeccos’s Modified Eagle Medium (LG- DMEM; 
Gibco, ThermoFisher Scientific, Basel, Switzerland) at a 
final concentration of 0.5 mg/ml. The cells were then 
seeded into T75 culture flask (Techno Plastic Products 
[TPP], Alsardingen, Switzerland) and placed for 16 to 20 
hours on a shaker in the incubator (37°C, 5% CO2) for di-
gestion. The digested material was filtered through a 70 
μm cell strainer (BD Falcon; Becton- Dickinson, Brussels, 
Belgium). The cells were transferred into a T150 culture 
flask and cultured in growth media which contained LG- 
DMEM + 10% FCS (Gibco, ThermoFisher Scientific) and 1% 
antibiotics (100 μg/ml penicillin, 100 IU/ml streptomycin; 
Gibco, ThermoFisher Scientific). For the first week Primocin 
(InvivoGen, Toulouse, France; distributed by Lucerna- 
Biochem, Lucerne, Switzerland) with a concentration of 
100 μg/ml was applied. Table I provides an overview of the 
hACL donors, which were used for this study.
Real-time life cell imaging of wound scratch assays us-
ing ACL-LCs. The in vitro scratch wound assay was per-
formed using the WoundMaker 96- pin tool, a mechani-
cal device to create homogenous, 700 to 800 µm wide 
scratches in cell monolayers (Essen Bioscience, Royston, 
UK) (Figure  2). Cells were seeded in LG- DMEM + 10% 
FCS into specialized multi- well plates (Essen Bioscience) 
with an optimized cell density of 15,000 cells per well. 
At about 90% confluency, a wound was induced. The 
cells were washed twice with PBS to remove cell debris 
and the desired plasmin concentrations were added. The 
plasmin was derived from human plasma (Sigma- Aldrich, 
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Fig. 1
Diagram of the difference in the healing process of the anterior cruciate ligament (ACL) inside the joint capsule filled with synovial fluid compared to the 
medial collateral ligament (MCL), which is located outside of the joint capsule, thus lacking contact with synovial fluid, which contains plasmin to some 
extent. The original hypothesis was formulated by Kiapour and Murray3 and has been redrawn here to illustrate the principle.
Table I. List of anterior cruciate ligament donors used with the IncuCyte S3 
System (Essen Bioscience, Royston, UK).
Donor ID and passage 
number Age, yrs Sex
Significance of 
WCS*
ACL42 P2 47 F n.s.
ACL48 P3 27 F p ≤ 0.01
ACL49 P2 41 M p ≤ 0.001
ACL72 P2 67 F p ≤ 0.001
ACL75 P3 25 F p ≤ 0.001
ACL77 P2 53 F n.s.
*One- way analysis of variance (ANOVA).
WCS, wound closing speed; n.s., not significant
St. Louis, Missouri, USA) and was diluted in PBS to a stock 
solution of 0.5 µg/µl. To ensure that wound closure does 
not occur mainly due to cell proliferation, the serum 
concentration was reduced in all experimental groups 
to 5% right after scratch induction. The rate of wound 
closure was monitored with time- lapse microscopy and 
images were acquired at 15- minute intervals from the 
time the cells filled the 'induced wound'. The procedure 
was followed the guidelines of wound scratch assays as 
described in Grada et al.15 Human- derived plasmin was 
added to LG- DMEM with different concentrations (0, 0.1, 
1, 10, and 50 µg/ml), and two controls were included to 
test the influence of plasmin on wound healing. Serum- 
free LG- DMEM was used as a negative control and media 
containing PDGF (50 µg/ml; Peprotech, London, UK) and 
10% FCS (growth medium) were run as two positive con-
trols. The experimental groups and the media concentra-
tions are outlined in Table II.
Relative gene expression analysis. All cells were ly-
sed in 1 ml TRI reagent (Molecular Research Center, 
Cincinnati, Ohio, USA) and frozen at -80°C prior ex-
traction on day zero and after 24 hours, cells and 5 µl 
of poly- acryl carrier were added (Molecular Research 
Center, Cincinnati, Ohio, USA). For RNA extraction 100 
ml of 1- bromo-3- chloropropane (BCP; Sigma Aldrich, 
Buchs, Switzerland) was added and a phase separation 
was performed followed by silicon membrane bound pu-
rification technique using GenElute total RNA extraction 
kit (Sigma- Aldrich). The remaining genomic DNA was 
digested using AMP- D1 DNase I Kit (Sigma- Aldrich), as 
described earlier.17
The relative gene expression for selected tendon- 
relevant extracellular matrix (ECM) homeostasis genes 
was investigated as previously described.18 Tendon and 
ACL- LC markers including collagen I and III, and tenom-
odulin, were tested. In addition, gene expression of two 
matrix metalloproteinases, enzymes, which regulate 
matrix turnover, were investigated (Table  III). MMP3 
(stromelysin 1) and MMP13 (collagenase 3) both break 
down collagen and proteoglycans quickly and are known 
to play a role in ligament remodelling.19 RNA integrity was 
controlled on selected samples by standard sensitivity 
RNA- chip using Experion Automated Electrophoresis 
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Fig. 2
Experiment design of the performed study to test the effect of plasmin, a component of the synovial fluid, on the wound healing behaviour of primary 
anterior cruciate ligament (ACL)- derived ligamentocytes (ACL- LCs). a) Experiment set- up. b) Customized main image processing chain using open source 
CellProfiler software to segment the ACL- LCs and wound closure in the wound scratch assays. "OTSU" refers to the image thresholding algorithm named after 
Nobuyuki Otsu.16 c) Example of phase- contrast images taken at a 10× magnification with the IncuCyte S3 system demonstrating customized segmentation of 
ACL- LCs. LC, ligamentocyte; qPCR, quantitative PCR.
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Table II. Overview of media used for the experiment groups.
Experiment group Medium Supplements
Positive control 1 LG- DMEM + 100 μg/ml penicillin + 100 IU/ml streptomycin 10% FCS
Positive control 2 LG- DMEM + 100 μg/ml penicillin + 100 IU/ml streptomycin 5% FCS + 50 μg/ml PDGF
Negative control LG- DMEM + 100 μg/ml penicillin + 100 IU/ml streptomycin Serum- free medium
Experiment groups LG- DMEM + 100 μg/ml penicillin + 100 IU/ml streptomycin 5% FCS + different plasmin concentration (0, 0.1, 1, 10, and  
50 µg/ml)
DMEM, Eagle's minimum essential medium; FCS, fetal calf serum; LG, low glucose medium; PDGF, platelet- derived growth factor.
Table III. Polymerase chain reaction primers used for quantitative 
polymerase chain reaction. Primers were designed in Beacon designer v.7.7 
(Premier Biosoft, Palo Alto, California, USA) and evaluated for efficiency.
mRnA (Gene ID) Primer pairs
Reference gene
18S (100008588) F: CGA TGC GGC GGC GTT ATT C, R: GTG 
GCA GTG ATG GAA
Anabolic gene
COL1A2 (1278) F: TCA CCT ACA GCA CGC TTG, R: GGT CTG 
TTT CCA GGG TTG
COL2A1 (1280) F: AGC AAG AGC AAG GAG AAG, R: GGG AGC 
CAG ATT GTC ATC
COL3A1 (1281) F: ATA TCA AAC ACG CAA GGC, R: GAT TAA 
AGC AAG AGG AAC AC
TNC (3371) F: TCT CTG CAC ATA GTG AAA AAC AAT ACC, 
R: TCA AGG CAG TGG TGT CTG TGA
TNMD (64102) F: ACA AGC AAG TGA GGA AGA A, R: GAC 
GGC AGT AAA TAC AAC AAT
Catabolic genes
ADAMTS4 (9507) F: TTCCTGGACAATGGCTATGG, R: 
GTGGACAATGGCGTGAGT
MMP3 (4314) F: GAC AAA GGA TAC AAC AGG GAC, R: TGA 
GTG AGT GAT AGA GTG GG
MMP13 (4322) F: GTT CAA GGA ATC CAG TCT CTC TAT GG, 
R: TGG GTC ACA CTT CTC TGG TGT TT
F, Forward primer; R, Reverse primer; mRNA, messenger RNA
System (Bio- Rad, Reinach, Switzerland). Complementary 
DNA (cDNA) was synthesized with the all- in- one cDNA 
Synthesis SuperMix from bimake (Houston, Texas, USA). 
The 18S ribosomal RNA gene was chosen as the reference 
gene, which is usually highly expressed in cells and inde-
pendent from experimental conditions.20 Customized 
primers designed with Beacon Designer (v.7.7; Premier 
Biosoft, Palo Alto, California, USA) were tested for effi-
ciency and synthesized by Microsynth (Balgach, Switzer-
land) as described previously.17,21 The qPCR was run in a 
two- step protocol with an annealing temperature of 61°C 
(Table III) and the 2× SYBR green supermix from bimake. 
Melting curve analysis was run as a standard procedure 
for control for the specificity of the amplicons.
To calculate relative gene expression, the Livak & 
Schmidt method (2-∆∆Ct)22 was used using the CFX-96 
cycler software v3.1 (Bio- Rad); 18S (ribosomal RNA) was 
applied as the reference gene for all samples.23 Rela-
tive gene expression levels for samples were calculated 
relative to the no plasmin reference sample (i.e. with 
LG- DMEM + 5% FCS) of each ACL donor after 24 hours 
of exposure.
Image processing and segmentation. The data were ana-
lyzed with CellProfiler version 3.1.9, which is open source 
software for quantitative analysis of biological images.24 
The main image processing steps that were established 
are depicted in Figure  2. Firstly, the cell shapes were 
smoothed by implementing a Gaussian and median fil-
ter, which removed particles that were disturbing the 
segmentation of the wound area. The smoothened im-
age was then rescaled by histogram normalization. The 
OTSU’s thresholding method16 was then applied to search 
the threshold value for which the sum of foreground and 
background spreads was at its maximum (see Figure 2). 
In an erosion step single cells, which were detected in the 
wound site, were removed. Dilation caused the identified 
objects to dilate and to form a confluent layer. A Gaussian 
'blur' was applied and the cell monolayers were detected 
finally as objects. The images were then masked and the 
cell areas were calculated.
Statistical analysis. The statistical analyses were per-
formed with GraphPad Prism 7.0d (GraphPad Software, 
La Jolla, California, USA). To quantify WCS of real- time 
microscopy images a least- square linear regression line 
was fitted to the wound confluence data within the first 
24 hours. The slopes were then compared with one- way 
analysis of variance (ANOVA) and Tukey’s multiple com-
parison test. Gene expression analyses were tested iden-
tically and additionally, if significantly different from the 
control (no plasmin control) using a hypothetical mean 
of 1.0. A p- value of < 0.05 was considered significant.
Results
Wound scratch assays of primary ACL-LCs. Real- time mi-
croscopy revealed tiff images and videos, which visu-
alized the WCR of the different experimental groups 
(Supplementary Videos 1 and 2). The analysis of the 
slopes from linear regression of each individual scratch as-
say is depicted in Figure 3. Overall statistical significance 
of WCR of single experiments using one- way ANOVA was 
found in four out of six donors (Table I). In two out of the 
six donors (donors 72 and 75) there were significant de-
creases in WCR observed between the 50 µg plasmin and 
the no plasmin group (p = 0.001 in both donors, Tukey's 
multiple test); two donors reacted in the opposite way 
(Figure 3). However, comparing the WCR slopes of all six 
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Fig. 3
Statistical comparisons of slopes of the least- square fitted linear regressions, defined as wound closing rate (WCR) of the wound scratch assays. a) to f) 
Wound confluence over time for anterior cruciate ligament (ACL)- derived ligamentocytes (ACL- LCs) of each of the six different donors: on the left side wound 
confluency is presented for the 72- hour period; on the right side the estimated slopes after 24 hours are shown for the nine technical replicates for each assay. 
The significance from pairwise testing is stated as follows: non- significant (ns) p > 0.05, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. FCS, fetal calf 
serum; NC, negative control; PC, positive control; PDGF, platelet- derived growth factor.
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Fig. 4
Overall means of slopes across six donors of wound scratch assays to investigate the effects of plasmin on primary anterior cruciate ligament (ACL)- derived 
ligamentocytes (ACL- LCs). The means and SDs of the wound closing rate, given as area %/hour, were inferred from the slopes by fitting a linear regression 
within the first 24 hours after induction of the wound using the WoundMaker 96- pin tool (six biological replicates = human ACL donors). FCS, fetal calf 
serum; NC, negative control; PC, positive control; PDGF, platelet- derived growth factor. The significance from pairwise testing is stated as follows: non- 
significant p > 0.05; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001.
donors resulted in highly significant changes (p < 0.001, 
one- way ANOVA; Figure 4). From the pairwise compari-
sons, however, only the PDGF positive control was highly 
significant (p < 0.001, Tukey's multiple test) from all oth-
ers and the serum- free control versus the 10% FCS con-
trol was found to be significant (p < 0.05, Tukey's multi-
ple test) (Figure 4). If the slopes were compared pairwise 
across all six donors there were no significant differences 
between the means of the 50 µg, or among any of the 
weaker plasmin concentrations to the no plasmin control 
(Figure 4). These results demonstrated the sensitivity of 
the chosen wound scratch assay.
Gene expression analyses. Relative gene expression after 
the scratching of monolayer and the exposure to plas-
min was quantified after 24 hours. The gene expression 
did not significantly change among groups (Figure  5). 
Exceptions were obtained for ADAMTS4 between FCS 
and the negative control group. There were trends vis-
ible of up- regulation of ADAMTS4, MMP3, and MMP13 
with increasing concentrations of plasmin in the medium 
(Figure 5).
Discussion
The current experimental data showed evidence of reduc-
tion of WCS with an increased plasmin concentration in 
four out of six donors (Table  I and Figure 3). However, 
averaging across all six donors the data did not confirm 
that plasmin concentration seemed to have an effect on 
the wound- closing behaviour of primary ACL- LCs using 
slope comparisons among groups of each donor.
The finding that PDGF clearly accelerated WCR was 
evident in wound scratch assays but also supported by 
qPCR (Figures 3 to 5). Thus, PDGF should be discussed 
for improved wound healing in the clinics for ACL ther-
apeutic purposes. Platelet- rich plasma (PRP) isolated 
from peripheral blood has been demonstrated to contain 
higher amounts of PDGF, and thus remains a feasible 
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Fig. 5
Relative gene expression in the anterior cruciate ligament (ACL)- derived ligamentocytes (ACL- LCs) of six human ACL donors of induced wound scratch assays 
and exposure to different concentrations of plasmin in medium. a) Collagen type 1 (COL1), b) Collagen type 3 (COL3), c) Tenomodulin (TNMD), d) Tenascin 
(TNC), e) ADAMTS-4, f) Stromelysin 1 (MMP3), g) Collagenase 3 (MMP13). The significance is stated as follows: non- significant p > 0.05, *p ≤ 0.05. FCS, fetal 
calf serum; PDGF, platelet- derived growth factor.
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Fig. 6
Diagram of factors required for the fibrinolysis system in wound healing. Schema drawn based on Gysen P et al, Rość D et al, and Kummer JA et al.9,10,14 ECM, 
extracellular matrix; tPA, tissue plasminogen activator; uPA, urokinase- type plasminogen activator.
clinically approved method to 'boost' healing.21,25 These 
results suggested that either plasmin is not important 
for the observed poor wound healing response or other 
factors in combination with plasmin should be tested. 
Plasmin, however, seemed to modulate gene expres-
sion of TNMD but also ADAMTS4, MMP3, and MMP13. 
It is possible that these gene expression changes were 
induced by the addition of plasmin, thus switching on the 
enzymatic cascade after exposure to plasmin. This study 
describes for the first time the effect of plasmin presence 
on the MMP gene expression of primary ACL- LCs.
The fibrinolytic system is involved in the dissolution 
of fibrin clots during wound healing. It degrades fibrin 
and fibrinogen to products that act to inhibit the enzyme 
thrombin and therefore reduce transformation of fibrin-
ogen to fibrin. The activation of the fibrinolytic system 
depends on the conversion of the plasma zymogen 
plasminogen to the serine protease plasmin. Plasmin-
ogen is mainly synthesized in the liver and circulates in 
the blood. The plasma concentration of plasminogen is 
approximately 200 µg/ml.26 Considerable amounts are 
also found in extravascular fluids. The main physiological 
function of plasmin is blood clot fibrinolysis and resto-
ration of normal blood flow. When a blood clot forms, 
the blood cells and proteins become cross- linked with 
fibrin fibres. Fibrin formation induces activation of plas-
minogen. There are two types of plasminogen activators: 
tissue plasminogen activator (tPA) and urokinase plas-
minogen activator (uPA) (see Figure 6). Tissue plasmin-
ogen activator is synthesized by endothelium cells and 
oocytes. As plasminogen, tPA possesses a high affinity 
for fibrin. Its activity increases sharply in the presence of 
fibrin. This makes tPA a useful therapeutic agent, since its 
activity is largely confined to the sites of recent throm-
bosis.27 uPA is synthesized by leucocytes, tumour cells, 
macrophages, and fibroblasts. The uPA molecule has 
no affinity to fibrin. It activates plasminogen preferably 
in plasma and ECM and it is thought to play a role in 
rheumatoid arthritis. Urokinase plasminigen activator 
has been identified as the predominant synovial fluid 
plasminogen activator in joint diseases.14 The activ-
ities of tPA and uPA are regulated by the plasminogen 
activator inhibitor (PAI)-1 and PAI-2 (see Figure  6). The 
importance of the plasminogen/plasmin system in 
wound healing has been demonstrated in one study.28 
Plasminogen- deficient mice have a delay in the epithelial-
ization of skin wounds. The same was observed for uPA/
tPA double- deficient mice.29 In contrast, mice deficient in 
PAI-1 experienced accelerated wound healing. Several 
in vitro studies showed that plasmin induces signal-
ling pathways that are important for cell activation and 
expression of many pro- inflammatory mediators during 
wound healing.30 The fibrinolytic system is also involved 
in degradation of ECM, embryogenesis, cell migration, 
tissue remodelling, angiogenesis, inflammation, onco-
genesis, and metastasis.12
To advance ACL research future designs are needed 
to combine influences of cytokine and/or fibrin clots 
combined with automated wound healing models.31 
This article is a first step towards the development of a 
high- throughput screening platform to test chemicals 
or specific substances from the synovial fluid of the knee 
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joint in a 2D wound scratch model. Here, apart from 
customized imaging processing software using artifi-
cial intelligence, customized bioreactors will also be 
needed that allow for a combination of mechanics and 
biology.32,33 Current commercial solutions for real- time 
imaging are often limited to 2D models but would need 
to be optimized for 3D applications, such as screening 
scaffolds and tissues under mechanical loading.
Factors other than plasmin content in synovial fluid, 
such as mechanical loading, are likely to play an addi-
tional key role for the healing of the ACL.34,35 The ACL 
undergoes daily cyclic loading during natural motion of 
the knee.36,37 Therefore, if surgical sutures were consid-
ered as rigid fixation materials, the likelihood of failure 
of the repair- construct will be due to the cyclic loads 
that act on the ACL during the healing phase, resulting 
from natural knee motion.38 This concept was proven in 
biomechanical research, which involved a variety of ACL 
fixation techniques.39 Therefore, it was in the interest of 
some clinical research groups to introduce a dynamic 
form of fixation to address the biomechanical barriers of 
healing.39,40 The first clinical results of such an approach 
were recently published and demonstrated beneficial 
outcomes for patients using a dynamic intraligamentary 
stabilization technique.41 It was also recently found that 
in case of ruptures the anterolateral ligament may act as a 
secondary stabilizer in the knee joint kinematics.35
To summarize these results, it was demonstrated that 
increasing plasmin concentration had a significant effect 
on the WCR of ACL- LCs in vitro for four out of the six 
donors, especially increasing the plasmin concentration 
to 50 µg/ml which is equivalent value of plasmin concen-
tration in the synovial fluids (Table I and Figure 3).13 
However, comparing the means of the slopes of all six 
donors no statistical significance was found. There were 
visible trends of up- regulation of ADAMTS4, MMP3, and 
MMP13 with increasing concentrations of plasmin in the 
medium.
Supplementary material
  Two supplementary videos that demonstrate a 
representative wound scratch assay of a respon-
sive donor (Supplementary Video 1, ACL72) and a 
non- responsive donor (Supplementary Video 2, ACL48).
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